1. Home
  2. MNOV vs SQNS Comparison

MNOV vs SQNS Comparison

Compare MNOV & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
  • SQNS
  • Stock Information
  • Founded
  • MNOV 2000
  • SQNS 2003
  • Country
  • MNOV United States
  • SQNS France
  • Employees
  • MNOV N/A
  • SQNS N/A
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • SQNS Semiconductors
  • Sector
  • MNOV Health Care
  • SQNS Technology
  • Exchange
  • MNOV Nasdaq
  • SQNS Nasdaq
  • Market Cap
  • MNOV 91.7M
  • SQNS 85.7M
  • IPO Year
  • MNOV 2005
  • SQNS 2011
  • Fundamental
  • Price
  • MNOV $1.90
  • SQNS $3.11
  • Analyst Decision
  • MNOV Strong Buy
  • SQNS Strong Buy
  • Analyst Count
  • MNOV 1
  • SQNS 1
  • Target Price
  • MNOV $9.00
  • SQNS $7.50
  • AVG Volume (30 Days)
  • MNOV 21.3K
  • SQNS 107.6K
  • Earning Date
  • MNOV 02-18-2025
  • SQNS 02-11-2025
  • Dividend Yield
  • MNOV N/A
  • SQNS N/A
  • EPS Growth
  • MNOV N/A
  • SQNS N/A
  • EPS
  • MNOV N/A
  • SQNS 1.65
  • Revenue
  • MNOV N/A
  • SQNS $30,555,000.00
  • Revenue This Year
  • MNOV N/A
  • SQNS $10.14
  • Revenue Next Year
  • MNOV N/A
  • SQNS $8.54
  • P/E Ratio
  • MNOV N/A
  • SQNS $1.90
  • Revenue Growth
  • MNOV N/A
  • SQNS N/A
  • 52 Week Low
  • MNOV $1.12
  • SQNS $0.85
  • 52 Week High
  • MNOV $2.55
  • SQNS $7.43
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 45.15
  • SQNS 50.30
  • Support Level
  • MNOV $1.87
  • SQNS $3.00
  • Resistance Level
  • MNOV $2.06
  • SQNS $3.64
  • Average True Range (ATR)
  • MNOV 0.08
  • SQNS 0.22
  • MACD
  • MNOV 0.00
  • SQNS -0.01
  • Stochastic Oscillator
  • MNOV 47.48
  • SQNS 34.78

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

Share on Social Networks: